CIK 0001679628
- Emerging growth company
JUPITER NEUROSCIENCES, INC.
Sign in to watch- Ticker
- JUNS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474828381
- Phone
- +1 561-406-6154
- Business address
- 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL, 33477
- Former names
- Jupiter Orphan Therapeutics, Inc.
- 4 Open-market buy Pres + Chief Business Officer bought 750 shares at an average $1.03 ($772)
- 4 Open-market buy CEO and Chairman bought 3,600 shares at an average $1.02 ($3,667)
- 4 Open-market buy Pres + Chief Business Officer bought 1,800 shares at an average $1.03 ($1,855)
- 4 Open-market buy CEO and Chairman bought 7,816 shares at an average $1.02 ($7,986)
- 4 Option exercise Director acquired 10,781 shares (option exercise)
- 4 Option exercise Director acquired 21,750 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 2 · 36 filings